Aiming to be global vax hub


THE government is in talks with the World Health Organisation as well as six drug companies to become a global hub for manufacturing vaccines, its health minister said.

Detailing the ambitious strategy for the first time, Budi Gunadi Sadikin said in an interview that Indonesia would kickstart the initiative by prioritising purchases of Covid-19 vaccines from companies that shared technology and set up facilities in Indonesia.

“We are working with the WHO to be one of the global manufacturing hubs for mRNA,” he said, adding he had directly lobbied WHO director-general Tedros Adhanom Ghebreyesus.

“The WHO has pointed to South Africa as the first location, and I said that logically, Indonesia should be the second,” he said.

The new “technology transfer hubs” are part of a WHO strategy to widely distribute vaccine production and build capacity in developing countries to make new generation vaccines like Moderna and Pfizer’s nucleic acid-based mRNA jabs which can be quickly adapted to handle new virus variants.

Efforts to develop a base for Covid-19 vaccine production in South Africa will focus on trying to replicate Moderna’s shot, but a lack of progress in talks with the US company mean the project will take time, a senior WHO official said.

Budi said Indonesia was keen to build expertise in mRNA vaccines, as well as viral vector shots such as those produced by AstraZeneca.

A WHO spokesperson said Indonesia was one of 25 low- and middle-income countries to express interest in hosting a vaccine hub.

Budi said Indonesia was well-placed to export vaccines around the world, especially as it is the world’s most populous Muslim-majority country and could guarantee that its jabs were halal.

Indonesia has grappled with one of the most severe outbreaks of Covid-19 in Asia and has recorded more than 4.1 million infections and 139,000 deaths, although public health experts say the true figures are likely several times higher.

Indonesia’s rate of infections and deaths has declined sharply in recent weeks but, with only 25% of its target population of 208 million people fully inoculated against Covid-19, it still has a major vaccination effort ahead, especially as it likely will have to provide third booster shots.

Budi said Indonesian pharmaceutical companies are in discussions with vaccine manufacturers and developers Anhui, Walvax, Sinovac, Genexine, Arcturus Therapeutics and Novavax.

The talks range from basic “fill and finish” to upstream production and research and development, he added.

“We open the same opportunities also to AstraZeneca. We are also open to the existing partner Pfizer,” he said.

“We are open to anyone.”

Bambang Heriyanto, corporate secretary of Bio Farma, confirmed the talks were on and the first step was to collaborate on the transfer of technology. It would take two or three years to build a fully operational production facility, he said.

Budi said Indonesia would use its leadership of the G-20 group of countries starting in December to promote global health security and prepare for the next pandemic after the coronavirus, also known as SARS-CoV-2. — Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Aseanplus News

Myanmar working on welcoming back foreign tourists by early 2022
Cambodia reports only 195 new Covid-19 cases on Monday (Oct 18), lowest number recorded this year
Laos capital Vientiane reporting lower Covid-19 cases as govt confirms 285 new infections on Monday (Oct 18)
Time to reconsider new ways to deliver healthcare, says Brunei health minister
Sabah seeks to become major regional pineapple supplier
Indonesia and Malaysia concerned over AUKUS nuclear subs plan
Philippines' Synergy Grid sets guidance for up to US$386 million share sale
Though numbers have fallen short, the 'Phuket Sandbox' sets the stage for Thailand's tourism revival
Vietnam SEA Games pushed back to May 2022 due to Covid-19 concerns, says OCM
A shot in the arm against Covid-19 in the Philippines, says the Inquirer

Others Also Read


Vouchers